Glenmark Pharmaceuticals gets tentative ANDA approval for its generic version of Lo Loestrin Fe

From USFDA

Glenmark Pharmaceuticals has been granted tentative approval by the United States Food & Drug Administration for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.01 mg, Ethinyl Estradiol Tablets USP, 0.01 mg and Ferrous Fumarate Tablets, 75 mg, the generic version of Lo Loestrin Fe (niorethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate) Tablets of Allergen Pharms International.

Powered by Capital Market - Live News